Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This study found that women with androgenetic alopecia and alopecia areata had significantly lower serum ferritin levels compared to women without hair loss.

This article discusses the various cosmetic, medical, and surgical treatment options for androgenetic alopecia but reports no new clinical findings, emphasizing the importance of differential diagnosis in treatment planning.

In this study, chronic telogen effluvium was identified as the most common cause of alopecia in patients with systemic lupus erythematosus, with trichoscopy proving effective in diagnosing different alopecia patterns.

In this study, oral iron replacement therapy showed improvement in hair loss severity for some women with low serum ferritin levels, but not all responded.

This study found that postmenopausal women experience two distinct patterns of hair changes, with diffuse scalp hair loss linked to body hair loss and age, and frontal hair loss associated with increased facial hair and a younger age.

The issue concluded that various skin conditions have different effective treatments and factors influencing them.

Mimicking growth factors in a topical solution can prolong hair growth phase and reduce hair loss without side effects.

This article reviews female pattern hair loss in women, highlighting its characteristics, treatment options, and the need to differentiate it from other hair loss conditions, and reports no new clinical results.

This study found a significant association between lower serum ferritin levels and chronic diffuse hair loss in women of reproductive age, particularly in cases of alopecia areata and androgenetic alopecia.

This study identified xerosis and diffuse hair loss as the most common skin manifestations in patients with hypothyroidism, observed in 38.09% and 34.8% of participants, respectively.

This review discusses telogen effluvium, including its causes, symptoms, diagnostic methods, and treatment strategies, without presenting new clinical findings.

This article discusses telogen effluvium, emphasizing the importance of understanding its natural progression and highlights the need for a detailed patient evaluation but provides no new clinical results.

The paper suggests improving diagnosis and treatment of telogen effluvium but does not recommend a new classification system.

This article reviews the concept of telogen effluvium and emphasizes the importance of identifying triggers and using diagnostic investigations to determine the cause of hair loss, without reporting new results.

This review discusses telogen effluvium, including its triggers, clinical presentations, and management options, and does not report new research findings, emphasizing the need for identification and exclusion of underlying causes.

This review discusses the causes and understanding of telogen effluvium, a form of hair loss following physiological stress, and provides no new clinical findings.

This review discusses the complex diagnosis and management of telogen effluvium, noting its high prevalence, psychosocial impact, and need for quantitative diagnostic techniques, but it reports no new research findings.

This retrospective study observed that telogen effluvium, a type of diffuse hair loss, frequently occurs in females aged 18–30 following SARS-CoV-2 infection, often accompanied by nutritional deficiencies, suggesting an association between COVID-19 and micronutrient deficiency, with acute cases being most common but chronic cases possible.

This paper reviews diffuse androgen-dependent alopecia and chronic telogen effluvium in women, highlighting diagnostic challenges and management issues, but reports no new clinical findings; the authors suggest effective treatments are available.

This article discusses distinguishing features of Diffuse Alopecia Areata and Fibrosing Alopecia in a Pattern Distribution, but reports no new clinical results.

This article discusses post-COVID-19 hair loss, highlighting potential misdiagnoses between different types and the expanded role of dermatologists; no new clinical findings are reported.

This review discusses diagnostic approaches for women with diffuse, nonscarring hair loss and reports no new clinical results.

Hair loss that spreads out can often fix itself or be treated by finding and handling the cause.

This article reviews various causes of diffuse hair loss, highlighting the importance of identifying triggers through thorough examination for effective treatment and emphasizing patient education in management; it reports no new clinical findings.

This study found that low ferritin levels are associated with higher telogen ratios in women with diffuse hair loss, suggesting an important role of ferritin in telogen effluvium diagnosis.

This study found that chronic telogen effluvium, female pattern hair loss, and telogen effluvium accounted for the majority of non-scarring diffuse alopecia cases in women at a tertiary urban hospital.

Metoprolol and propranolol may cause hair loss.

This review explores post-COVID-19 syndromes and the underlying mechanisms, including persistent inflammation, autoimmunity, and possible viral reservoirs, but reports no new clinical results.

This article discusses the presence of dirty dots as a normal trichoscopic finding in children, noting they are not observed in adults or other age groups, and reports no new results.

This article is a letter to the editor discussing hair graying and loss potentially induced by imatinib mesylate, but it does not provide new research results.